Preventing mother-to-child HIV transmission in low-income countries

The World Health Organization has reported that over 500,000 children under 15 years of age become infected with HIV every year, mainly through mother-to-child transmission during pregnancy, childbirth, and breastfeeding (MTCT).

Transmission around the time of birth can be prevented with antiretroviral drugs and safer delivery and feeding practices. However, in many low-income settings a woman may have few opportunities for HIV testing before she goes into labor. Therefore, programs in which immediate HIV testing is made available within the context of the labor ward, together with counseling and treatment services, may help to reduce the extent of MTCT in developing countries.

In this issue of PLoS Medicine, Nitika Pant Pai and colleagues evaluated such a program, carried out in a rural hospital in Maharashtra State, India. The researchers found that most women presenting in labor did not already know their HIV status, but the overwhelming majority accepted HIV testing on the labor ward. As part of the program, women were enrolled, received counseling, their test results, and referral for treatment interventions (if appropriate) within 40-60 minutes. As a result of the program, 15 women (of 1,222 in total who received HIV testing) were found to be HIV infected, of whom 11 were newly diagnosed at the point of care. These results demonstrate the feasibility of introducing rapid, round-the-clock HIV testing within a labor ward in a low-income setting.

Future challenges involve establishing how these findings can be applied more widely in other low-income settings to upgrade and expand existing HIV testing services.

In an expert commentary on the new research, David Celentano (Bloomberg School of Public Health, Johns Hopkins University), who was not involved in the study, says: “It is clear that the labor and delivery setting offers the final opportunity to detect and prevent mother-to-child transmission of HIV. The program outlined by Pai and colleagues is efficient, acceptable, and leads to reduced morbidity.”

Source: Public Library of Science

Bacteria in small sea life yield new way to make potential cancer drugs
Researchers led by a University of Utah medicinal chemist have developed a novel method to make drugs for cancer and other diseases from bacteria found in sponges and other small ocean creatures.
Sensitive nanowire disease detectors made by Yale scientists
Yale scientists have created nanowire sensors coupled with simple microprocessor electronics that are both sensitive and specific enough to be used for point-of-care (POC) disease detection, according to a report in Nano Letters.
Scientists Find First Immune Responses to HIV Infection Ineffective
(PhysOrg.com) -- Scientists have identified the very first antibodies to appear in the wake of HIV infection and have concluded that they are virtually impotent in mounting a meaningful defense against the invading virus.
New findings indicate HIV/AIDS pandemic began around 1900, earlier than previously thought
New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, suggesting that growing urbanization in colonial Africa set the stage for the HIV/AIDS pandemic.
Disease diagnosis in just 15 minutes
Testing for diseases such as cancer and multiple sclerosis could soon be as simple as using a pregnancy testing kit.
Existing anti-obesity drugs may be effective against flu, hepatitis and HIV
Viruses dramatically increase cellular metabolism, and existing anti-obesity drugs may represent a new way to block these metabolic changes and inhibit viral infection, according to a study published today in the journal Nature Biotechnology.
Researcher micro-sizes genetics testing
Using new "lab on a chip" technology, James Landers hopes to create a hand-held device that may eventually allow physicians, crime scene investigators, pharmacists, even the general public to quickly and inexpensively conduct DNA tests from almost anywhere, without need for a complex and expensive central laboratory.
As personalized, genomic medicine takes off, four developing countries show the way for others
Developing countries that want the benefits of cutting-edge health care possibilities based on the genetic variation of individual citizens and sub-populations need to foster the new science at home, says a major new Canadian study published today by Nature Publishing Group.

Preventing mother-to-child HIV transmission in low-income countries

Related stories:

News discussion: